RLI.NYSERli CORP

Form 4: RLI Corp CEO Craig Kliethermes Reports Stock Option Exercise and Share Disposals

Sentiment:

SEC Form 4


RLI Corp's CEO, Craig W. Kliethermes, reported exercising stock options and disposing of shares to cover tax obligations, resulting in adjustments to his beneficial ownership.

Summary

  • On July 30, 2024, Craig W. Kliethermes, CEO of RLI Corp, exercised stock options to acquire 4,000 shares of common stock at a price of $56.14.
  • Following the exercise, Kliethermes disposed of 2,506 shares to satisfy tax obligations at a price of $150.33.
  • After these transactions, Kliethermes directly owns 62,148 shares of RLI Corp common stock.
  • He also indirectly owns 7,659.29 shares through an ESOP and 11,293.269 shares through an Executive Deferred Compensation plan.
  • Kliethermes holds various stock options with exercise prices ranging from $75.66 to $143.15, exercisable in increments until 2032.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies. It provides transparency regarding the transactions of company insiders.

Comparison to Industry Standards

  • Executive stock option exercises and subsequent share disposals for tax purposes are standard practice across publicly listed companies.
  • Companies like Chubb, Travelers, and Progressive also regularly report similar Form 4 filings for their executives.
  • The option exercise prices and vesting schedules are generally in line with industry norms for executive compensation packages designed to align management interests with shareholder value.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
  • The filing provides transparency to stakeholders regarding executive compensation and ownership.

Key Dates

DateDescription
05/03/2019Date of stock option grant with exercise price of $56.14.
05/02/2020Date of stock option grant with exercise price of $75.66.
08/21/2021Date of stock option grant with exercise price of $86.24.
05/06/2022Date of stock option grant with exercise price of $106.02.
11/10/2022Date of $7.00 extraordinary dividend declaration, impacting stock option grant prices.
05/05/2023Date of stock option grant with exercise price of $109.6.
05/04/2024Date of stock option grant with exercise price of $136.59.
07/30/2024Date of stock option exercise and share disposal.
07/31/2024Date of signature on the Form 4 filing.
08/01/2024Date of stock option grant with exercise price of $134.41.
11/01/2024Date of stock option grant with exercise price of $135.22.
02/01/2025Date of stock option grant with exercise price of $135.22.
05/02/2025Date of stock option grant with exercise price of $143.15.
05/03/2026Expiration date for stock options granted on 05/03/2019.
05/02/2027Expiration date for stock options granted on 05/02/2020.
08/21/2028Expiration date for stock options granted on 08/21/2021.
05/06/2029Expiration date for stock options granted on 05/06/2022.
05/05/2030Expiration date for stock options granted on 05/05/2023.
05/04/2031Expiration date for stock options granted on 05/04/2024.
08/01/2031Expiration date for stock options granted on 08/01/2024.
11/01/2031Expiration date for stock options granted on 11/01/2024.
02/01/2032Expiration date for stock options granted on 02/01/2025.
05/02/2032Expiration date for stock options granted on 05/02/2025.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.